Molecular mechanisms and genetic features of cholangiocarcinoma: implications for targeted therapeutic strategies.

Although OS did not reach statistical significance, this outcome may have been affected by the fact that 70% of patients in the placebo arm crossed over to ivosidenib after disease progression [ 140 ].

also in 111,027 other papers